HC Wainwright Initiates Flex Pharma At Buy

by Monica Gerson, Benzinga Staff Writer

April 14, 2015 9:41 AM | 11 seconds read | Make a Comment

HC Wainwright initiated coverage on

Flex Pharma, Inc.FLKS

with a Buy rating. The target price for Flex Pharma is set to $40. Flex Pharma shares closed at $19.46 yesterday.

Posted In: Initiation Analyst Ratings HC Wainwright

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.